Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Quantification of C1 inhibitor activity using a chromogenic automated assay: analytical and clinical performances. | Clin Chem Lab Med | 2024 | 38861040 | PubTator, text mining | PubMed |
| A Novel Peptidome Technology for the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease by Selected Reaction Monitoring. | J Alzheimers Dis | 2024 | 38848173 | PubTator, text mining | PubMed |
| Identifying hub genes in response to ustekinumab and the impact of ustekinumab treatment on fibrosis in Crohn's disease. | Front Immunol | 2024 | 38840917 | PubTator, text mining | PubMed |
| Protein profile of circulating extracellular vesicles reveals biomarker candidates for diagnosis of post-traumatic deep vein thrombosis. | Clin Chim Acta | 2024 | 38796050 | PubTator, text mining | PubMed |
| Relationship of Hematological Profiles with the Serum Complement System in Patients with Systemic Lupus Erythematosus. | Biomedicines | 2024 | 38790929 | PubTator, text mining | PubMed |
| Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmas. | Allergy Asthma Proc | 2024 | 38755781 | PubTator, text mining | PubMed |
| Exploring disease-specific metabolite signatures in hereditary angioedema patients. | Front Immunol | 2024 | 38726011 | PubTator, text mining | PubMed |
| Extremely Late Diagnosis of Hereditary Angioedema Type I in an Elderly Female. | Cureus | 2024 | 38690445 | PubTator, text mining | PubMed |
| [Case series of hereditary angioedema patients and use of tranexamic acid treatments in prophylaxis and acute crisis, experience in Perú]. | Rev Alerg Mex | 2024 | 38683073 | PubTator, text mining | PubMed |
| The CC2D2B is a novel genetic modifier of the clinical phenotype in patients with hereditary angioedema due to C1 inhibitor deficiency. | Gene | 2024 | 38679185 | PubTator, text mining | PubMed |
| The future of therapeutic options for hereditary angioedema. | Ann Allergy Asthma Immunol | 2024 | 38679158 | PubTator, text mining | PubMed |
| Special Issue: "Genes and Human Diseases". | Int J Mol Sci | 2024 | 38674038 | PubTator, text mining | PubMed |
| Potential shared pathogenic mechanisms between endometriosis and inflammatory bowel disease indicate a strong initial effect of immune factors. | Front Immunol | 2024 | 38660311 | PubTator, text mining | PubMed |
| A complement C4-derived glycopeptide is a biomarker for PMM2-CDG. | JCI Insight | 2024 | 38587076 | PubTator, text mining | PubMed |
| Differentiated pattern of complement system activation between MOG-IgG-associated disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder. | Front Immunol | 2024 | 38576611 | PubTator, text mining | PubMed |
| Use of Nonhuman Sera as a Highly Cost-Effective Internal Standard for Quantitation of Multiple Human Proteins Using Species-Specific Tryptic Peptides: Applicability in Clinical LC-MS Analyses. | J Proteome Res | 2024 | 38533909 | PubTator, text mining | PubMed |
| Humoral complementomics - exploration of noninvasive complement biomarkers as predictors of renal cancer progression. | Oncoimmunology | 2024 | 38487624 | PubTator, text mining | PubMed |
| Complex analysis of the national Hereditary angioedema cohort in Slovakia - Identification of 12 novel variants in SERPING1 gene. | World Allergy Organ J | 2024 | 38486718 | PubTator, text mining | PubMed |
| Aberrant H3K4me3 modification of immune response genes in CD4+ T cells of patients with systemic lupus erythematosus. | Int Immunopharmacol | 2024 | 38432146 | PubTator, text mining | PubMed |
| Potential drug targets for gastroesophageal reflux disease and Barrett's esophagus identified through Mendelian randomization analysis. | J Hum Genet | 2024 | 38429412 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=15